Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-25 Sale | 2026-03-26 8:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 3,844 | $21.47 | $82,531 | 33,827 (Direct) | View |
| 2026-02-09 Sale | 2026-02-10 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 6,950 | $23.38 | $162,491 | 20,554 (Direct) | View |
| 2021-12-14 Sale | 2021-12-15 4:06 pm | Angion Biomedica Corp. | ANGN | Rhodes Jennifer J See Remarks | 451 | $2.4171 | $1,090 | 30,399 (Direct) | View |
| 2021-11-15 Sale | 2021-11-16 4:09 pm | Angion Biomedica Corp. | ANGN | Rhodes Jennifer J See Remarks | 433 | $4.4 | $1,905 | 30,850 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-24 Exercise | 2026-03-26 8:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 7,515 | $0 | 33,827 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-10 6:00 pm | N/A 2036-03-05 | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 117,073 | $0 | 117,073 (Direct) | View |
| 2026-02-06 Exercise | 2026-02-10 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 12,944 | $0 | 20,554 (Direct) | View |
| 2025-03-24 Option Award | 2025-03-26 8:03 pm | N/A 2035-03-23 | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 132,351 | $0 | 133,371 (Direct) | View |
| 2024-02-06 Option Award | 2024-02-08 5:09 pm | N/A 2034-02-05 | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 152,478 | $0 | 152,478 (Direct) | View |
| 2022-03-02 Option Award | 2022-03-04 4:21 pm | N/A 2032-03-01 | Angion Biomedica Corp. | ANGN | Rhodes Jennifer J See Remarks | 275,000 | $0 | 450,000 (Direct) | View |